Financing
Other, net
Vertex Pharmaceuticals Other, net decreased by 136.4% to -$400.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 20.0%, from -$500.00K to -$400.00K. Over 4 years (FY 2021 to FY 2025), Other, net shows a downward trend with a -10.2% CAGR.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026May 5, 2026
How to read this metric
Fluctuations are often non-recurring; significant changes should be analyzed via footnotes to determine if they represent structural shifts in financing strategy.
Detailed definition
This metric aggregates miscellaneous cash flows related to financing activities that do not fall into primary categories...
Peer comparison
Standard line item in cash flow statements; varies significantly by company based on the complexity of their capital structure.
Metric ID:
financing_proceeds_from_payments_for_other_financing_activitiesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.60M | $1.40M | $1.40M | $1.30M | $400.00K | $700.00K | $1.10M | $1.10M | $1.10M | $1.10M | $450.00K | $3.50M | $900.00K | $900.00K | $900.00K | -$500.00K | $2.00M | $1.10M | $1.10M | -$400.00K |
| QoQ Change | — | -12.5% | +0.0% | -7.1% | -69.2% | +75.0% | +57.1% | +0.0% | +0.0% | +0.0% | -59.1% | +677.8% | -74.3% | +0.0% | +0.0% | -155.6% | +500.0% | -45.0% | +0.0% | -136.4% |
| YoY Change | — | — | — | — | -75.0% | -50.0% | -21.4% | -15.4% | +175.0% | +57.1% | -59.1% | +218.2% | -18.2% | -18.2% | +100.0% | -114.3% | +122.2% | +22.2% | +22.2% | +20.0% |
Range-$500.00K – $3.50M
CAGR-25.3%
Avg YoY Growth+22.8%
Median YoY Growth+2.3%
Other, net at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's other, net?
- Vertex Pharmaceuticals (VRTX) reported other, net of -$400.00K in Q1 2026.
- How has Vertex Pharmaceuticals's other, net changed year-over-year?
- Vertex Pharmaceuticals's other, net increased by 20.0% year-over-year, from -$500.00K to -$400.00K.
- What is the long-term trend for Vertex Pharmaceuticals's other, net?
- Over 4 years (2021 to 2025), Vertex Pharmaceuticals's other, net has grown at a -10.2% compound annual growth rate (CAGR), from $5.70M to $3.70M.
- What does other, net mean?
- Net cash flows from secondary or miscellaneous financing activities.